Aurora Cannabis Inc. (ACB)
NASDAQ: ACBHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ACB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $273.50M
- EPS (TTM)
- -$0.19
- Dividend yield
- None
- 52-week range
- 2.56 – 6.36
- Day range
- 4.15 – 4.34
- Volume / Avg
- 899.95K / 1.31M
- Beta
- —
- Shares outstanding
- 65.74M
52-week range
ACB stock today
Aurora Cannabis (ACB) closed at $4.16 on Nov 20, down 2.35% (-$0.10), versus the S&P 500's 3.70% decline. At this level, ACB sits in the middle of its 52-week range of $2.56 to $6.36: 34.6% below the high, set on Dec 18, 2025 and 62.5% above the low. ACB is down 1.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 1.2%.
Aurora Cannabis has posted a net loss over the last twelve months (EPS of -$0.19), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Aurora Cannabis
Company profileAurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Miguel Martin
- Headquarters
- Edmonton, AB
- Employees
- 1,028
- Website
- auroramj.com
Analyst forecast
ForecastConsensus (2 analysts)
underperform
- Strong buy 0
- Buy 0
- Hold 1
- Sell 1
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $0.03 vs $-0.03
- Surprise
- +200.00%
ACB news
All ACB news- Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?NasdaqTLRY, ACB, CFR
- The Big Winner From the Aurora Cannabis-Organigram Deal: CuraleafNasdaqACB, OGI
- Which of These 5 Cannabis Stocks Has the Strongest Balance Sheet?NasdaqCRON, ACB, CGC, SNDL
- Curaleaf Issues Statement Regarding Alternative Proposal for Aurora CannabisPR Newswire
- Organigram to Acquire Aurora and Establish a Global Cannabis LeaderBusiness WireOGI, ACB
- Aurora Cannabis to Host Second Quarter 2027 Investor Conference CallBusiness Wire
- ACB's Q2 Earnings on Deck: International Medical Cannabis in FocusNasdaqACB, BDX, IDXX, PAHC
- Aurora Cannabis Stock Has Soared 25% Since Curaleaf First Made an Offer to Buy Its Business. Here's Why I Think It Can Go Even HigherNasdaq
Aurora Cannabis peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TLRYTilray Brands Inc. | 1.89 | -8.70% | $279.32M | vs ACB |
| SNDLSNDL Inc. | 1.17 | -5.65% | $285.20M | vs ACB |
| USNAUSANA Health Sciences Inc. | 12.94 | -1.67% | $239.24M | vs ACB |
| MDWDMediWound Ltd. | 13.59 | +0.37% | $195.56M | vs ACB |
| CGCCanopy Growth Corporation | 0.427 | -9.97% | $191.99M | vs ACB |
| NAGENiagen Bioscience Inc. | 1.84 | -1.60% | $145.72M | vs ACB |
| GLASGlass House Brands Inc. Subordinate Voting Shares | 1.18 | -2.48% | $118.11M | vs ACB |
| ISPRIspire Technology Inc. | 1.23 | -3.15% | $71.05M | vs ACB |
Indexes, lists and sector
Aurora Cannabis stock FAQ
What is Aurora Cannabis's stock price today?
ACB last traded at $4.16 as of Nov 20, 4:00 PM EST, down 2.35% on the day. Prices are delayed at least 15 minutes.
Does Aurora Cannabis pay a dividend?
No. Aurora Cannabis does not currently pay a regular cash dividend.
Who is Aurora Cannabis's CEO?
Mr. Miguel Martin is the chief executive officer of Aurora Cannabis Inc., which has about 1,028 employees.
Has ACB ever split its stock?
Yes. The most recent ACB stock split was a 1-for-10 split on Feb 20, 2024, one of 2 splits on record.
What is the ACB 52-week high?
The 52-week high for ACB is $6.36 and the 52-week low is $2.56. The stock is currently 34.6% below its high.